In our study, using the CT26/Balb-c model, multiple cycles of 5-FU decreased the proliferation of cytotoxic T-cells specific to CT26, indicating the potential for 5-FU to attenuate anti-tumour immunity by inhibiting the proliferation of tumour-specific T-cell populations [27]. This evidence concerns the gene DDX53 and neoplasm.